Is there a role for antiangiogenic therapy, bevacizumab, in the treatment of recurrent digestive bleeding due to angiodysplasia in Glanzmann's thrombasthenia? (Q45855667)
Jump to navigation
Jump to search
scientific article published on 28 June 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Is there a role for antiangiogenic therapy, bevacizumab, in the treatment of recurrent digestive bleeding due to angiodysplasia in Glanzmann's thrombasthenia? |
scientific article published on 28 June 2016 |
Statements
1 reference
Is there a role for antiangiogenic therapy, bevacizumab, in the treatment of recurrent digestive bleeding due to angiodysplasia in Glanzmann's thrombasthenia? (English)
1 reference
J Dréanic
C Flaujac
V Roussel-Robert
N Stieltjes
S Combe-Marzelle
R Coriat
28 June 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference